Literature DB >> 32828466

The pathophysiology of neurodegenerative disease: Disturbing the balance between phase separation and irreversible aggregation.

Chelsea J Webber1, Shuwen Eric Lei1, Benjamin Wolozin2.   

Abstract

Liquid-liquid phase separation (LLPS) brings together functionally related proteins through the intrinsic biophysics of proteins in a process that is driven by reducing free energy and maximizing entropy. The process of LLPS allows proteins to form structures, termed membrane-less organelles. These diverse, dynamic organelles are active in a wide range of processes in the nucleus, cytoplasm, mitochondria and synapse, and ranging from bacteria to plants to eukaryotes. RNA and DNA present long chained charged polymers that promote LLPS. Consequently, many RNA binding proteins (RBPs) and DNA binding proteins form membrane-less organelles. However, the highly concentrated phase separated state creates conditions that also promote formation of irreversible protein aggregates. Mutations in RNA and DNA binding proteins that increase the stability of irreversible aggregates also increase the accumulation of irreversible aggregates directly and from membrane-less organelles. Many of the RBPs that exhibit disease-linked mutations carry out cytoplasmic actions through stress granules, which are a pleiotropic type of RNA granule that regulates the translational response to stress. Phosphorylation and oligomerization of tau facilitates its interactions with RBPs and ribosomal proteins, affecting RNA translation; we propose that this is a major reason that tau becomes phosphorylated with stress. Persistent stress leads to the accumulation of irreversible aggregates composed of RBPs or tau, which then cause toxicity and form many of the hallmark pathologies of major neurodegenerative diseases. This pathophysiology ultimately leads to multiple forms of neurodegenerative diseases, the specific type of which reflects the temporal and spatial accumulation of different aggregating proteins.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyotrophic lateral sclerosis; FUS; Frontotemporal dementia; Gibbs free energy; Nuclear pore; Nucleolus; Phase separation diagrams; TDP-43; Van de Waals forces

Mesh:

Substances:

Year:  2020        PMID: 32828466     DOI: 10.1016/bs.pmbts.2020.04.021

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  7 in total

Review 1.  Liquid-liquid phase separation as an organizing principle of intracellular space: overview of the evolution of the cell compartmentalization concept.

Authors:  Iuliia A Antifeeva; Alexander V Fonin; Anna S Fefilova; Olesya V Stepanenko; Olga I Povarova; Sergey A Silonov; Irina M Kuznetsova; Vladimir N Uversky; Konstantin K Turoverov
Journal:  Cell Mol Life Sci       Date:  2022-04-20       Impact factor: 9.261

Review 2.  Dr. Jekyll and Mr. Hyde? Physiology and Pathology of Neuronal Stress Granules.

Authors:  Pureum Jeon; Jin A Lee
Journal:  Front Cell Dev Biol       Date:  2021-02-25

3.  Stochasticity, Entropy and Neurodegeneration.

Authors:  Peter K Panegyres
Journal:  Brain Sci       Date:  2022-02-07

Review 4.  Liquid-Liquid Phase Separation of TDP-43 and FUS in Physiology and Pathology of Neurodegenerative Diseases.

Authors:  Jenny L Carey; Lin Guo
Journal:  Front Mol Biosci       Date:  2022-02-02

Review 5.  Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance.

Authors:  Doris Loh; Russel J Reiter
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

Review 6.  Pathophysiology of stress granules: An emerging link to diseases (Review).

Authors:  Jihui Wang; Yixia Gan; Jian Cao; Xuefen Dong; Wei Ouyang
Journal:  Int J Mol Med       Date:  2022-02-09       Impact factor: 4.101

Review 7.  Fused in Sarcoma (FUS) in DNA Repair: Tango with Poly(ADP-ribose) Polymerase 1 and Compartmentalisation of Damaged DNA.

Authors:  Maria V Sukhanova; Anastasia S Singatulina; David Pastré; Olga I Lavrik
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.